Cancer and patients with end-stage renal failure.
作者信息
Curtis J R
出版信息
Br Med J (Clin Res Ed). 1982 Jan 9;284(6309):69-70. doi: 10.1136/bmj.284.6309.69.
Abstract
摘要
相似文献
1
Cancer and patients with end-stage renal failure.癌症与终末期肾衰竭患者。
Br Med J (Clin Res Ed). 1982 Jan 9;284(6309):69-70. doi: 10.1136/bmj.284.6309.69.
2
The significance of cancer after renal transplantation.肾移植后癌症的意义。
J Urol. 1979 Sep;122(3):298-9. doi: 10.1016/s0022-5347(17)56374-0.
3
Treatment of end-stage renal disease in children.儿童终末期肾病的治疗。
Pediatr Ann. 1981 Jan;10(1):65-73.
4
Complications and Mortality in Chronic Renal Failure Patients Undergoing Total Joint Arthroplasty: A Comparison Between Dialysis and Renal Transplant Patients.接受全关节置换术的慢性肾衰竭患者的并发症及死亡率：透析患者与肾移植患者的比较
J Arthroplasty. 2016 Feb;31(2):465-72. doi: 10.1016/j.arth.2015.09.003. Epub 2015 Sep 9.
5
Renal transplantation (second of two parts).
N Engl J Med. 1979 Nov 8;301(19):1038-48. doi: 10.1056/NEJM197911083011905.
6
Preventing hepatitis B and hepatitis C virus infections in end-stage renal disease patients: back to basics.预防终末期肾病患者的乙型肝炎和丙型肝炎病毒感染：回归基础
Hepatology. 1999 Jan;29(1):291-3. doi: 10.1002/hep.510290132.
7
Labyrinthine pathology of chronic renal failure patients treated with hemodialysis and kidney transplantation.
Laryngoscope. 1974 Sep;84(9):1489-506. doi: 10.1288/00005537-197409000-00005.
8
[Disorders of lipid metabolism in patients with chronic renal failure and after kidney transplantation].[慢性肾衰竭患者及肾移植后患者的脂质代谢紊乱]
Pol Tyg Lek. 1992;47(31-33):667-70.
9
Renal cell carcinoma (RCC) arising in native kidneys of dialyzed and transplant patients: are they different entities?透析和移植患者的原肾发生的肾细胞癌（RCC）：它们是不同的实体吗？
BJU Int. 2012 Dec;110(11 Pt B):E570-3. doi: 10.1111/j.1464-410X.2012.11273.x. Epub 2012 Jun 22.
10
The pattern of excess cancer in dialysis and transplantation.透析和移植中癌症过多的模式。
Nephrol Dial Transplant. 2009 Oct;24(10):3225-31. doi: 10.1093/ndt/gfp331. Epub 2009 Jul 8.
引用本文的文献
1
Management of cytotoxic chemotherapy in patients undergoing dialysis: a still unresolved issue of onconephrology.透析患者细胞毒性化疗的管理：肿瘤肾脏病学中一个仍未解决的问题。
J Nephrol. 2024 Oct 15. doi: 10.1007/s40620-024-02102-7.
2
Identification of common molecular signatures of SARS-CoV-2 infection and its influence on acute kidney injury and chronic kidney disease.鉴定 SARS-CoV-2 感染的常见分子特征及其对急性肾损伤和慢性肾脏病的影响。
Front Immunol. 2023 Mar 21;14:961642. doi: 10.3389/fimmu.2023.961642. eCollection 2023.
3
Incidence risk of various types of digestive cancers in patients with pre-dialytic chronic kidney disease: A nationwide population-based cohort study.透析前慢性肾脏病患者各种消化道癌症的发病风险：一项全国基于人群的队列研究。
PLoS One. 2018 Nov 20;13(11):e0207756. doi: 10.1371/journal.pone.0207756. eCollection 2018.
4
Onco-nephrology: an appraisal of the cancer and chronic kidney disease links.肿瘤肾脏病学：对癌症与慢性肾脏病关联的评估
Nephrol Dial Transplant. 2015 Dec;30(12):1979-88. doi: 10.1093/ndt/gfu387. Epub 2015 Feb 3.
5
Association of cancer with moderately impaired renal function at baseline in a large, representative, population-based cohort followed for up to 30 years.在一项长达 30 年的大型、代表性、基于人群的队列研究中，基线时肾功能中度受损与癌症的相关性。
Int J Cancer. 2013 Sep 15;133(6):1452-8. doi: 10.1002/ijc.28144. Epub 2013 Mar 29.
6
Cancer in patients on chronic dialysis in Korea.韩国慢性透析患者中的癌症
J Korean Med Sci. 2009 Jan;24 Suppl(Suppl 1):S95-S101. doi: 10.3346/jkms.2009.24.S1.S95. Epub 2009 Jan 28.
7
Pyrexia of unknown origin (PUO) in a hemodialysis patient.一名血液透析患者的不明原因发热（PUO）
Int Urol Nephrol. 2007;39(4):1277-80. doi: 10.1007/s11255-007-9285-8. Epub 2007 Sep 26.
8
Prognosis of hepatocellular carcinoma after hepatectomy in patients with renal dysfunction.
World J Surg. 2005 Mar;29(3):375-81. doi: 10.1007/s00268-004-7515-0.
9
Increased incidence of neoplasia in chronic renal failure (20-year experience).慢性肾衰竭中肿瘤发生率的增加（20年经验）
Int Urol Nephrol. 2002;33(1):121-6. doi: 10.1023/a:1014489911153.
10
Bladder cancer in a patient on long-term haemodialysis.
Int Urol Nephrol. 1998;30(5):565-8. doi: 10.1007/BF02550546.
本文引用的文献
1
Cancer in patients receiving dialysis.接受透析治疗患者的癌症
Br Med J. 1980 Jun 14;280(6229):1401-3. doi: 10.1136/bmj.280.6229.1401.
2
Incidence of cancer in renal transplant recipients.肾移植受者的癌症发病率。
Proc Eur Dial Transplant Assoc. 1980;17:502-6.
3
High incidence of neoplasia in uremic patients receiving long-term dialysis. Cancer and long-term dialysis.接受长期透析的尿毒症患者肿瘤发生率高。癌症与长期透析。
Nephron. 1981;27(6):292-6. doi: 10.1159/000182073.
4
Rapid evolution of central nervous system lymphoma in renal transplant recipient.
Lancet. 1981 Oct 17;2(8251):868-9. doi: 10.1016/s0140-6736(81)91129-6.
5
Increased incidence of lymphoma after injections of mice with cells differing at weak histocompatibility loci.给小鼠注射在弱组织相容性位点存在差异的细胞后淋巴瘤发病率增加。
Science. 1966 Apr 1;152(3718):78-80. doi: 10.1126/science.152.3718.78.
6
Malignant lymphomas following allogenic disease: transition from an immunological to a neoplastic disorder.同种异体疾病后的恶性淋巴瘤：从免疫性疾病向肿瘤性疾病的转变。
Science. 1965 Sep 24;149(3691):1511-4. doi: 10.1126/science.149.3691.1511.
7
Transitional cell tumors of the renal pelvis in analgesic abusers.
Scand J Urol Nephrol. 1968;2(3):145-50. doi: 10.3109/00365596809135358.
8
Bilateral renal carcinoma associated with polycystic kidneys.双侧肾癌伴多囊肾
Br Med J. 1973 Aug 4;3(5874):273-4. doi: 10.1136/bmj.3.5874.273.
9
Malignant tumors arising de novo in immunosuppressed organ transplant recipients.免疫抑制的器官移植受者新发的恶性肿瘤。
Transplantation. 1972 Oct;14(4):407-17. doi: 10.1097/00007890-197210000-00001.
10
Risk of cancer in renal-transplant recipients.肾移植受者患癌风险
Lancet. 1973 Jul 14;2(7820):55-7. doi: 10.1016/s0140-6736(73)93256-x.
Zotero 插件